The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genomic profiling using a 435-gene panel provides a vision for precision medicine in Japanese gastric cancer.
 
Hiroshi Ichikawa
No Relationships to Disclose
 
Masayuki Nagahashi
No Relationships to Disclose
 
Yuko Kitagawa
Honoraria - Chugai Pharma; Ethicon; Nippon Kayaku; Olympus; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Ajinomoto (Inst); Asahi Kasei (Inst); Astellas Pharma (Inst); Boehringer Ingelheim (Inst); Chugai Pharma (Inst); CSL Behring (Inst); Daiichi Sankyo (Inst); Dainippon Sumitomo Pharma (Inst); GlaxoSmithKline (Inst); Kaken Pharmaceutical (Inst); Kowa (Inst); Kureha (Inst); Kyowa Hakko Kirin (Inst); Lilly (Inst); Medtronic (Inst); Merck Serono (Inst); Nippon Kayaku (Inst); Novartis (Inst); Otsuka (Inst); Otsuka (Inst); Pfizer (Inst); Sanofi (Inst); Shionogi (Inst); Taiho Pharmaceutical (Inst); Taisho Toyama Pharma (Inst); Takeda (Inst); Teijin Pharma (Inst); Tsumura & Co. (Inst); Yakult Honsha (Inst)
 
Kazuhiro Yoshida
Honoraria - Chugai Pharma; Daiichi Sankyo; EA Pharma; Lilly Japan; Merck Serono; Novartis; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Chugai Pharma (Inst); Dainippon Sumitomo Pharma (Inst); EA Pharma (Inst); Lilly Japan (Inst); MSD (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Yakult Honsha (Inst)
Travel, Accommodations, Expenses - Chugai Pharma; Daiichi Sankyo; EA Pharma; Lilly Japan; Merck Serono; Novartis; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Eiji Oki
No Relationships to Disclose
 
Hiroshi Yabusaki
No Relationships to Disclose
 
Satoru Nakagawa
No Relationships to Disclose
 
Nobuaki Sato
No Relationships to Disclose
 
Takaaki Hanyu
No Relationships to Disclose
 
Takashi Ishikawa
No Relationships to Disclose
 
Yusuke Muneoka
No Relationships to Disclose
 
Kizuki Yuza
No Relationships to Disclose
 
Yoshifumi Shimada
No Relationships to Disclose
 
Jennifer E. Ring
No Relationships to Disclose
 
Alexei Protopopov
No Relationships to Disclose
 
Stephen Lyle
No Relationships to Disclose
 
Yiwei Ling
No Relationships to Disclose
 
Shujiro Okuda
No Relationships to Disclose
 
Kazuaki Takabe
No Relationships to Disclose
 
Toshifumi Wakai
Research Funding - Denka Co., Ltd (Inst)